Latest News
THX Pharma secures European patent for Batten-1 in juvenile Batten disease
9 September 2026 - Biopharmaceutical company THX Pharma (Theranexus) (Euronext Growth Paris:ALTHX) and the Beyond Batten Disease Foundation (BBDF) announced on Wednesday that the European Patent Office has granted European patent No. EP 4 188 371, pr...
Lakewood-Amedex Biotherapeutics to present at H.C. Wainwright 28th Annual Global Investment Conference
9 September 2026 - Clinical-stage biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ:LABT) announced on Tuesday that its CEO, Kelvin Cooper, Ph.D., will deliver a virtual presentation at the H.C. Wainwright 28th Annual Global Investmen...
Orphalan commences Phase 3 study of trientine therapy in Wilson disease
9 September 2026 - French pharmaceutical company Orphalan Inc announced on Tuesday the launch of the TRADITiONAL Study, a global, multicentre Phase 3 clinical trial evaluating an investigational once-daily formulation of trientine tetrahydrochloride ...
Altesa BioSciences presents positive vapendavir clinical data at ERS International Congress 2026
9 September 2026 - Altesa BioSciences, a clinical-stage pharmaceutical company focused on chronic lung diseases including COPD and asthma, announced on Tuesday new clinical data showing that its investigational antiviral therapy, vapendavir, signific...
ZAGENO named Frost & Sullivan's 2026 North American Life Sciences E-Commerce Company of the Year
9 September 2026 - Market research and consulting firm Frost & Sullivan said on Tuesday that it has awarded ZAGENO, a procurement orchestration platform for life sciences, its 2026 North America Life Sciences E-Commerce Company of the Year Recogn...